CPT1A-mediated fat oxidation, mechanisms, and therapeutic potential
IR Schlaepfer, M Joshi - Endocrinology, 2020 - academic.oup.com
Energy homeostasis during fasting or prolonged exercise depends on mitochondrial fatty
acid oxidation (FAO). This pathway is crucial in many tissues with high energy demand and …
acid oxidation (FAO). This pathway is crucial in many tissues with high energy demand and …
Cardiac metabolism—a promising therapeutic target for heart failure
H Noordali, BL Loudon, MP Frenneaux… - Pharmacology & …, 2018 - Elsevier
Both heart failure with reduced ejection fraction (HFrEF) and with preserved ejection fraction
(HFpEF) are associated with high morbidity and mortality. Although many established …
(HFpEF) are associated with high morbidity and mortality. Although many established …
m6A‐Modified circTET2 Interacting with HNRNPC Regulates Fatty Acid Oxidation to Promote the Proliferation of Chronic Lymphocytic Leukemia
Z Wu, X Zuo, W Zhang, Y Li, R Gui, J Leng… - Advanced …, 2023 - Wiley Online Library
Chronic lymphocytic leukemia (CLL) is a hematological malignancy with high metabolic
heterogeneity. N6‐methyladenosine (m6A) modification plays an important role in …
heterogeneity. N6‐methyladenosine (m6A) modification plays an important role in …
Randomized controlled trial of perhexiline on regression of left ventricular hypertrophy in patients with symptomatic hypertrophic cardiomyopathy (RESOLVE-HCM trial …
R Ananthakrishna, SL Lee, J Foote, BC Sallustio… - American Heart …, 2021 - Elsevier
Background The presence and extent of left ventricular hypertrophy (LVH) is a major
determinant of symptoms in patients with hypertrophic cardiomyopathy (HCM). There is …
determinant of symptoms in patients with hypertrophic cardiomyopathy (HCM). There is …
[HTML][HTML] The antianginal drug perhexiline displays cytotoxicity against colorectal cancer cells in vitro: a potential for drug repurposing
Simple Summary Cancer cells frequently have an altered metabolism to support their
increased proliferative and invasive activity. Perhexiline, a drug used to treat some …
increased proliferative and invasive activity. Perhexiline, a drug used to treat some …
Fatty acid oxidation is an adaptive survival pathway induced in prostate tumors by HSP90 inhibition
HSP90 is a molecular chaperone required for stabilization and activation of hundreds of
client proteins, including many known oncoproteins. AUY922 (luminespib), a new …
client proteins, including many known oncoproteins. AUY922 (luminespib), a new …
Increased acylcarnitines in infant heart failure indicate fatty acid oxidation inhibition: towards therapeutic options?
J Issa, P Lodewyckx, H Blasco… - ESC Heart …, 2023 - Wiley Online Library
Aims Heart failure in adults is characterized by reduction of long‐chain fatty acid oxidation in
favour of carbohydrate metabolism. This adaptive phenomenon becomes maladaptive …
favour of carbohydrate metabolism. This adaptive phenomenon becomes maladaptive …
Drugs that affect cardiac metabolism: focus on perhexiline
CR Chong, B Sallustio, JD Horowitz - Cardiovascular drugs and therapy, 2016 - Springer
Approaches to the pharmacotherapy of angina pectoris have previously centred on the
concept that a transient imbalance between myocardial oxygen “demand” and supply within …
concept that a transient imbalance between myocardial oxygen “demand” and supply within …
[HTML][HTML] Advances on minimally invasive approach for benign total hysterectomy: a systematic review
M de Paula Andres, GM Borrelli, MS Abrão - F1000Research, 2017 - ncbi.nlm.nih.gov
Hysterectomy is one of the most commonly performed gynecologic surgeries, mainly for
uterine myomas, abnormal uterine bleeding, and prolapses. It can be performed through …
uterine myomas, abnormal uterine bleeding, and prolapses. It can be performed through …
Emerging drugs for the treatment of angina pectoris
CR Chong, GJ Ong, JD Horowitz - Expert opinion on emerging …, 2016 - Taylor & Francis
Introduction: Angina pectoris, or symptomatic myocardial ischaemia, reflects an impairment
of coronary blood flow, and usually a deficiency of available myocardial energetics …
of coronary blood flow, and usually a deficiency of available myocardial energetics …